Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Summary

Spinal cord injury (SCI) is associated with severe neuropathic pain that is often refractory to all pharmacological intervention. Preliminary data suggest brivarecetum is a mechanism-based pharmacological intervention for neuropathic pain in SCI. This randomized, placebo-controlled pilot clinical trial will assess feasibility of a 3-month treatment course with brivarecetum.

Timeline

Start

2021-02-01

Primary completion

2024-03-31

Completion

2024-09-01

Drugs

Indications